264 related articles for article (PubMed ID: 23185794)
1. Treatment of malignant ovarian germ cell tumors and preservation of fertility.
Zhang R; Sun YC; Zhang GY; Wu LY; Zuo J
Eur J Gynaecol Oncol; 2012; 33(5):489-92. PubMed ID: 23185794
[TBL] [Abstract][Full Text] [Related]
2. Reproductive outcomes of 105 malignant ovarian germ cell tumor survivors: a multicenter study.
Tamauchi S; Kajiyama H; Yoshihara M; Ikeda Y; Yoshikawa N; Nishino K; Utsumi F; Niimi K; Suzuki S; Kikkawa F
Am J Obstet Gynecol; 2018 Oct; 219(4):385.e1-385.e7. PubMed ID: 30086295
[TBL] [Abstract][Full Text] [Related]
3. Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution.
Hu T; Fang Y; Sun Q; Zhao H; Ma D; Zhu T; Wang C
Surg Oncol; 2019 Dec; 31():8-13. PubMed ID: 31446304
[TBL] [Abstract][Full Text] [Related]
4. [Clinical analysis of 15 cases of malignant ovarian germ cell tumors with lung metastasis].
Liu Y; Ren T; Feng FZ; Wan XR; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):40-4. PubMed ID: 22455692
[TBL] [Abstract][Full Text] [Related]
5. Survival and reproductive function after treatment of malignant germ cell ovarian tumors.
Zanetta G; Bonazzi C; Cantù M; Binidagger S; Locatelli A; Bratina G; Mangioni C
J Clin Oncol; 2001 Feb; 19(4):1015-20. PubMed ID: 11181664
[TBL] [Abstract][Full Text] [Related]
6. Treatment of malignant ovarian germ cell tumors with preservation of fertility: a report of 28 cases.
Wu PC; Huang RL; Lang JH; Huang HF; Lian LJ; Tang MY
Gynecol Oncol; 1991 Jan; 40(1):2-6. PubMed ID: 1846603
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of prognostic factors of malignant ovarian tumor after fertility-preserving treatment].
Zeng DY; Shen K; Huang HF; Wu M; Pan LY; Yang JX; Lang JH
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(36):2562-5. PubMed ID: 16321304
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of malignant ovarian germ-cell tumors treated in Chiang Mai University Hospital over a nine year period.
Neeyalavira V; Suprasert P
Asian Pac J Cancer Prev; 2014; 15(12):4909-13. PubMed ID: 24998562
[TBL] [Abstract][Full Text] [Related]
9. Reproductive function after treatment of ovarian germ cell malignancy.
Anita AN; Rushdan MN
Med J Malaysia; 2012 Feb; 67(1):71-6. PubMed ID: 22582552
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic characteristics of malignant germ cell tumors in the ovaries of Korean women: a Korean Gynecologic Oncology Group Study.
Lee KH; Lee IH; Kim BG; Nam JH; Kim WK; Kang SB; Ryu SY; Cho CH; Choi HS; Kim KT;
Int J Gynecol Cancer; 2009 Jan; 19(1):84-7. PubMed ID: 19258947
[TBL] [Abstract][Full Text] [Related]
11. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.
Tangjitgamol S; Hanprasertpong J; Manusirivithaya S; Wootipoom V; Thavaramara T; Buhachat R
Acta Obstet Gynecol Scand; 2010; 89(2):182-9. PubMed ID: 19961281
[TBL] [Abstract][Full Text] [Related]
12. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.
Turkmen O; Karalok A; Basaran D; Kimyon GC; Tasci T; Ureyen I; Tulunay G; Turan T
J Adolesc Young Adult Oncol; 2017 Jun; 6(2):270-276. PubMed ID: 28085535
[TBL] [Abstract][Full Text] [Related]
13. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
Grischke EM; Wallwiener D; Bastert G
Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
[TBL] [Abstract][Full Text] [Related]
14. 8-year analysis of the prevalence of lymph nodes metastasis, oncologic and pregnancy outcomes in apparent early-stage malignant ovarian germ cell tumors.
Chatchotikawong U; Ruengkhachorn I; Leelaphatanadit C; Phithakwatchara N
Asian Pac J Cancer Prev; 2015; 16(4):1609-13. PubMed ID: 25743840
[TBL] [Abstract][Full Text] [Related]
15. Management of bilateral malignant ovarian germ cell tumors: a MITO-9 retrospective study.
Sigismondi C; Scollo P; Ferrandina G; Candiani M; Angioli R; Viganò R; Scarfone G; Mangili G
Int J Gynecol Cancer; 2015 Feb; 25(2):203-7. PubMed ID: 25569816
[TBL] [Abstract][Full Text] [Related]
16. The impact of lymphadenectomy on prognosis and survival of clinically apparent early-stage malignant ovarian germ cell tumors.
Qin B; Xu W; Li Y
Jpn J Clin Oncol; 2020 Mar; 50(3):282-287. PubMed ID: 31867612
[TBL] [Abstract][Full Text] [Related]
17. Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database.
Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb KM
Am J Clin Oncol; 2021 May; 44(5):195-199. PubMed ID: 33710136
[TBL] [Abstract][Full Text] [Related]
18. Outcomes and prognostic factors of patients with recurrent and persistent malignant ovarian germ cell tumors.
Wang J; Zhuo X; Yang J; Cao D; Shen K; Huang H; Wu M; Pan L; Xiang Y; Guo L
Arch Gynecol Obstet; 2020 Apr; 301(4):1021-1026. PubMed ID: 32198624
[TBL] [Abstract][Full Text] [Related]
19. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T
Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235
[TBL] [Abstract][Full Text] [Related]
20. Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study.
Mangili G; Sigismondi C; Gadducci A; Cormio G; Scollo P; Tateo S; Ferrandina G; Greggi S; Candiani M; Lorusso D
Int J Gynecol Cancer; 2011 Nov; 21(8):1414-21. PubMed ID: 21795985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
